Chemoinformaics analysis of Serpentine (alkaloid)
| Molecular Weight | 348.402 | nRot | 1 |
| Heavy Atom Molecular Weight | 328.242 | nRig | 26 |
| Exact Molecular Weight | 348.147 | nRing | 5 |
| Solubility: LogS | -5.14 | nHRing | 4 |
| Solubility: LogP | 3.547 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 14 |
| nHA | 5 | APOL | 53.0119 |
| nHD | 0 | BPOL | 27.2541 |
| QED | 0.633 |
| Synth | 4.055 |
| Natural Product Likeliness | 1.125 |
| NR-PPAR-gamma | 0.033 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.054 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.698 |
| MDCK | 0.0000345 |
| BBB | 0.875 |
| PPB | 0.947464 |
| VDSS | 1.107 |
| FU | 0.0451493 |
| CYP1A2-inh | 0.961 |
| CYP1A2-sub | 0.786 |
| CYP2c19-inh | 0.876 |
| CYP2c19-sub | 0.214 |
| CYP2c9-inh | 0.929 |
| CYP2c9-sub | 0.271 |
| CYP2d6-inh | 0.826 |
| CYP2d6-sub | 0.435 |
| CYP3a4-inh | 0.951 |
| CYP3a4-sub | 0.738 |
| CL | 5.661 |
| T12 | 0.169 |
| hERG | 0.611 |
| Ames | 0.959 |
| ROA | 0.19 |
| SkinSen | 0.067 |
| Carcinogencity | 0.974 |
| EI | 0.015 |
| Respiratory | 0.911 |
| NR-Aromatase | 0.178 |
| Antiviral | Yes |
| Prediction | 0.768529 |